VFY.AX
Technology Software - InfrastructureVitrafy Life Sciences Limited
A$3.11
-0.14 -4.31% today
Price History
Not enough data
Key Stats
Market Cap
237.11M
Avg Volume
68,689
EPS
-A$0.25
52W High
A$4.66
52W Low
A$1.20
Div. Yield
0.0%
Analyst Ratings
Buy0
Str Buy
3
Buy
0
Hold
0
Sell
0
Str Sell
Valuation
Forward P/E
-11.69
P/B Ratio
5.71
P/S Ratio
1134.51
EV/EBITDA
-12.20
EV/Revenue
976.53
Margins
Gross Margin 0.0%
Operating Margin 522.5%
Net Margin 0.0%
EBITDA Margin 0.0%
Growth & Returns
Return on Equity
(46.3%)
Return on Assets
(27.9%)
Liquidity & Leverage
Current Ratio
23.77
Quick Ratio
23.77
Debt / Equity
0.01
Total Cash
41.22M
Total Debt
302,574
About
Vitrafy Life Sciences Limited engages in the research, development, and commercialization of cryopreservation solutions in Australia. It offers cryopreservation medical devices, including freezers, thawers, and packaging solutions. The company also provides the LifeChain software platform, which controls, trace, tracks, and monitors quality of cryopreserved biomaterials, as well as the Guardion, non-medical hardware device. Its cryopreservation technology is used various applications, such as blood platelets, cell and gene therapies, and aquaculture and bovine breeding programs. Vitrafy Life Sciences Limited was incorporated in 2017 and is based in Melbourne, Australia.
www.vitrafy.com